Here are six things to note:
1. Implanet and South Korea-based L&K Biomed entered into a preliminary agreement in December 2017.
2. The partnership is designed to boost Implanet’s expansion in the U.S. and Asia.
3. Under the agreement, Implanet finalized a distribution agreement with Aegis Spine, a U.S. subsidiary of L&K Biomed.
4. Implanet will leverage its partnership with Aegis Spine to enhance its commercialization in the U.S.
5. The companies’ Asian and European teams are focused on regulatory, marketing and commercial efforts for two product line launches, as well.
6. In February, Implanet will welcome L&K BIOMED’s technical and sales teams at its headquarters in Bordeaux, France, for training.
More articles on devices:
Zimmer Biomet generates $7.8B in 2017 sales, spine segment sees 14% growth
Smith & Nephew opens specialized operations center in Costa Rica: 4 highlights
Dr. Michael Ries publishes book on inventing new hip, knee replacement devices — 5 highlights
